Souders Financial Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Souders Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-83,821	Closed	-$830K	–	142
2021 Q2	$830K	Buy	83,821 +9,869	+13%	+$104K	0.28%	76
2021 Q1	$853K	Buy	73,952 +4,799	+7%	+$55K	0.33%	64
2020 Q4	$667K	Buy	69,153 +4,651	+7%	+$44.6K	0.29%	67
2020 Q3	$621K	Buy	64,502 +4,925	+8%	+$52.1K	0.29%	66
2020 Q2	$735K	Buy	59,577 +16,216	+37%	+$183K	0.42%	55
2020 Q1	$389K	Buy	+43,361	New	+$444K	0.34%	65

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Souders Financial Advisors's TEVA Position: Q3 2021 in Review

Souders Financial Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2021, closing a stake of 83,821 shares — an estimated $830K sold.

Souders Financial Advisors first reported a position in TEVA in Q1 2020 and held it in 6 quarters. The position peaked at $853K in Q1 2021. 429 funds tracked by Wall St. Rank hold TEVA as of Q3 2021.

Souders Financial Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2021 after selling out during the quarter.
Souders Financial Advisors sold 83,821 Teva Pharmaceutical Industries Limited shares in Q3 2021, an estimated $830K.
Souders Financial Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q1 2020 and held it in 6 quarters.
Souders Financial Advisors's Teva Pharmaceutical Industries Limited position peaked at $853K in Q1 2021.
429 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2021.

Based on Souders Financial Advisors's 13F filing for Q3 2021, filed 3 Nov 2021.